Click for next page ( 24

The National Academies of Sciences, Engineering, and Medicine
500 Fifth St. N.W. | Washington, D.C. 20001

Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement

Below are the first 10 and last 10 pages of uncorrected machine-read text (when available) of this chapter, followed by the top 30 algorithmically extracted key phrases from the chapter as a whole.
Intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text on the opening pages of each chapter. Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.

Do not use for reproduction, copying, pasting, or reading; exclusively for search engines.

OCR for page 23
Appendix C Meeting One Agenda14 Meeting One, March 3, 2008 Committee on Review of Priorities in the National Vaccine Plan AGENDA National Academy of Sciences Building 2101 Constitution Avenue NW, Washington, DC Lecture Room 1:00 – 1:10 pm Welcome and Committee Introductions Claire V. Broome Committee Chair 1:10 – 1:20 pm Presentation Anand Parekh Acting Deputy Assistant Secretary for Health (Science and Medicine) Office of the Assistant Secretary for Health Department of Health and Human Services 14 A Website ( and listserv were created to provide information to the public about the committee’s work and to facilitate communication with the committee. Materials from the committee’s March 2008 meeting are available in electronic form on the website. Further, a list of materials reviewed by the committee (in the form in which they were reviewed) including all submissions of information from the public and many items not cited in this report, can be found in the study’s public access file, obtained from the National Academies Public Access Records Office at (202)334-3543 or 23

OCR for page 23
24 INITIAL GUIDANCE 1:20 – 1:50 pm Charge to the IOM Committee CAPT Raymond A. Strikas Medical Officer U.S. Public Health Service National Vaccine Program Office Department of Health and Human Services 1:50 – 2:05 pm Questions from the Committee 2:05 – 3:05 pm Key Dimensions of the National Vaccine Plan: Since 1994 and Future Melinda Wharton Deputy Director National Center for Immunizations and Respiratory Diseases Centers for Disease Control and Prevention Norman Baylor Director Office of Vaccines Research and Review Center for Biologics Evaluation Food and Drug Administration Carole A. Heilman Director Division of Microbiology and Infectious Diseases National Institute of Allergy and Infectious Diseases National Institutes of Health 3:05 – 3:20 pm Questions from the Committee 3:20 – 3:30 pm Break 3:30 – 4:10 pm Key Dimensions of the National Vaccine Plan, continued Jeffrey Kelman Chief Medical Officer Center for Beneficiary Choices Centers for Medicare and Medicaid Services Geoffrey Evans Director Division of Vaccine Injury Compensation Healthcare Systems Bureau Health Resources and Services Administration Jerome Donlon Chief Scientist Advisor & Medical Officer, Office of the Assistant Secretary for Public Health Emergency Preparedness Department of Health and Human Services 4:10 – 4:30 pm Questions from the Committee

OCR for page 23
APPENDIX C 25 4:30 – 4:45 pm Relationship Between the National Vaccine Plan and Healthy People 2020 RADM Penelope Slade Royall Director Office of Disease Prevention and Health Promotion Office of Public Health and Science, Office of the Secretary Department of Health and Human Service 4:45 – 5:15 pm Status of the New National Vaccine Plan Draft priorities for the National Vaccine Plan Walter Orenstein Professor of Medicine and Pediatrics Emory University School of Medicine Deputy Director, Emory Vaccine Center Consultant to the National Vaccine Plan Results of the first focus groups for public engagement Richard Tardif Oak Ridge Institute for Science and Education (ORISE) Consultant to the National Vaccine Plan Future plans for public engagement Roger Bernier Centers for Disease Control and Prevention 5:15 – 5:30 pm Questions from the Committee 5:30 – 5:45 pm Public Comments 5:45 pm Adjourn